The Controversy Around Pharmacy Benefit Managers

<p>Listen to Health Affairs' Leslie Erdelack and Marianne Amoss discuss the <a href="https://www.ohioattorneygeneral.gov/Files/Briefing-Room/News-Releases/Yost-v-Ascent.aspx">recent antitrust lawsuit against Express Scripts and Prime Therapeutics</a> regarding pharmacy benefit managers and alleged collusion to share drug pricing information.</p><p><a href="https://www.healthaffairs.org/do/10.1377/he20230324.525011/full/?utm_medium=podcast&amp;utm_source=this+week&amp;utm_campaign=de+beaumont+event">Join us for a Lunch and Learn Event on Health Care Workforces on April 4</a>. This event is supported by the <a href="https://debeaumont.org/">de Beaumont Foundation</a>.</p><p><strong>Related Links:</strong></p><ul> <li> <a href="https://www.commonwealthfund.org/publications/explainer/2019/apr/pharmacy-benefit-managers-and-their-role-drug-spending">Pharmacy Benefit Managers and Their Role in Drug Spending</a> (The Commonwealth Fund)</li> <li> <a href="https://healthpolicy.usc.edu/research/the-association-between-drug-rebates-and-list-prices/">The Association Between Drug Rebates and List Prices</a> (University of Southern California)</li> <li> <a href="https://www.fiercehealthcare.com/payers/ohio-ag-yost-files-suit-against-express-scripts-prime-therapeutics-over-rising-drug-costs">Ohio Attorney General David Yost Files Suit Against Express Scripts, Prime Therapeutics Over Rising Drug Costs</a> (<em>FierceHealthcare)</em> </li> <li> <a href="https://www.healthaffairs.org/do/10.1377/hp20220616.509976/?utm_medium=podcast&amp;utm_source=this+week&amp;utm_campaign=podcast">Podcast: Pharmacy Benefit Managers, the FTC &amp; You</a> (<em>Health Affairs This Week</em>)</li> <li> <a href="https://www.healthaffairs.org/do/10.1377/hpb20171409.000178/full/?utm_medium=podcast&amp;utm_source=this+week&amp;utm_campaign=brief">Health Policy Brief: Pharmacy Benefit Managers</a> (<em>Health Affairs</em>)</li> </ul><p>C<em>urrently, more than 70 percent of our content is freely available — and we’d like to keep it that way. </em